News

Novo Nordisk Says FDA Accepted New Drug Application for Wegovy Pill
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
Exclusive: US FDA asks some fired pharma user fee negotiation staff to return
The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...
The FDA Just Approved the First CRISPR-Edited Pigs for Food
PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.
US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
AI rules: FDA’s next step
Previous policy allowed up to a 12-month delay before articles were required to be made available to the public for free ...
In reversal, FDA rehires staff tasked with releasing public records
The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...
The FDA suspended a milk testing program. Is it safe to buy & drink in NC?
Yes. Though the FDA has suspended its proficiency testing program, milk products are still safe to consume in North Carolina.
Novo Nordisk shares jump as FDA accepts oral Wegovy application
Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...
Clinical Advisor22h
FDA Commissioner: No Major Reorganization, Just Smart Reforms
"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary ...
Medical Dialogues7h
FDA Approves Atzumi Nasal Powder for Acute Migraine Treatment
The US Food and Drug Administration (FDA) has approved Atzumi, a 5.2 mg dihydroergotamine (DHE) nasal powder, for the acute ...
Medindia3h
FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity
Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy® ...
Candy Recall Update as FDA Sets Risk Level
Milk not declared as an allergen was found in a Tennessee-based manufacturer's confectionery, not the first time candy has ...